- FDA Approves Longer-acting Calaspargase Pegol-mknl for ALL
- NICE Issues Diagnostics Guidance on Tumour Profiling Tests to Guide Adjuvant Chemotherapy Decisions in Early Breast Cancer
- FDA Approves Tagraxofusp-erzs for Blastic Plasmacytoid Dendritic Cell Neoplasm
- Spotlight on Digital Medicine
- FDA Approves Pembrolizumab for Merkel Cell Carcinoma
- FDA Approves Olaparib for First-line Maintenance Treatment of BRCA-mutated Advanced Ovarian Cancer
Providing practical opinion to support best practice for busy healthcare professionals